Improving the production of the anti-malarial artemisinin in artemisia annua

Projektinformationen

CINZIA BERTEA

ID Finanzhilfevereinbarung: QLK3-CT-2000-52058

Startdatum 16 Mai 2001

Enddatum 15 November 2002

Finanziert unter

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Gesamtkosten € 105 850,00

EU-Beitrag € 105 850,00

Koordiniert durch

N/A

Ziel

Artemisinin and its derivatives are a very promising new group of drugs against malaria. A biotechnological approach, including cloning and heterologous expression of the genes involved in its biosynthesis, will be employed in order to improve its production in Amanda plants.

Wissenschaftliches Gebiet

• medical and health sciences › health sciences › infectious diseases › malaria

Programm/Programme

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thema/Themen

• 1.1.1.-3. - Key action The "Cell factory"

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

RGI - Research grants (individual fellowships)

Koordinator

N/A

• EU-Beitrag: Keine Daten
• Gesamtkosten: Keine Daten